The Canadian Cancer Action Network (CCAN), in collaboration with CADTH, is pleased to invite you to a free, interactive workshop on how cancer drugs are reviewed through CADTH’s pan-Canadian Oncology Drug Review (pCODR) process.
October 25, 2016
1:00 p.m. to 4:00 p.m.
Grand Hotel & Suites Toronto
225 Jarvis St, Toronto, Ontario
RSVP: Please confirm your attendance at this workshop session via email at firstname.lastname@example.org, by October 20, 2016.
A copy of the Workshop Agenda is now available.
This is an opportunity for participants to:
- Meet with the Health Technology Assessment Patient Engagement Navigator (HTAPEN), and become familiar with the resources and tools available to support a patient submission to pCODR
- Get best practices, tips, and advice on how to plan and make a patient submission to pCODR
- Understand how cancer drugs are approved in Canada, with a focus on the pCODR process
- Learn how costs and benefits are considered in the health technology assessment (HTA) process, with a focus on cancer drugs
- Obtain insight directly from the patient members of the pCODR Expert Review Committee (pERC) on how patient evidence and information make a difference to the Committee’s recommendations.
Participants will have an opportunity to take part in a case study to understand the HTA recommendation process and to gain insight on how HTA committees make a funding recommendation for a cancer drug. Participants will have the chance to follow the deliberative framework used by pERC, which examines the overall clinical benefit, alignment of patient values, cost-effectiveness, and implementation considerations.
We encourage you to review the Tutorial: How Cancer Drug Funding Decisions Are Made, to help you get the most from the workshop.
To assist you with the costs to attend, CCAN and CADTH may consider providing patient group representatives with a modest travel award of up to $250. You are eligible to apply if you are a member of a patient group that:
- Has a means of contacting and communicating with its membership;
- Represents patients or caregivers affected by a specific condition; AND
- Is situated at least 50 km (one way) from the workshop location at the Grand Hotel Toronto (225 Jarvis St, Toronto, Ontario).
Participants must submit a letter confirming that they are members of an eligible patient group and ask to be considered for the travel award. Submit the request on your group’s letterhead by October 20, 2016, to email@example.com
We hope you will be able to join us for this workshop.